A0A2K5Z1V9 (A0A2K5Z1V9_MANLE) Mandrillus leucophaeus (Drill) (Papio leucophaeus)
Spindlin 1 UniProtKBInterProSTRINGInteractive Modelling
262 aa; Sequence (Fasta) ;
26 identical sequences
It is possible new templates exist for this target since these models were created.
Available Structures
19 Experimental Structures
Description | PDB ID | Oligo-state | Range | Ligands | ||
---|---|---|---|---|---|---|
Crystal Structure of Spindlin1 bound to H3(K4me3-K9me3) peptide |
Heteromer Q71DI3; Q9Y657; | |||||
Assess | ||||||
Crystal structure of human Spindlin1 in complex with a histone H3K4(me3) peptide |
Heteromer Q5TEC6; Q9Y657; | 1×GOL; 3×SO4; 1×NHE; | ||||
Assess | ||||||
Crystal Structure of Spindlin1-H3(K4me3-K9me2) complex |
Heteromer Q71DI3; Q9Y657; | |||||
Assess | ||||||
Crystal structure of Spindlin1/C11orf84 complex bound to histone H3K4me3K9me3 peptide |
Heteromer Q9BUA3; Q9Y657; | 6×BEN; 3×CL; 1×GOL; | ||||
Assess | ||||||
Crystal Structure of human Spindlin1-HBx complex |
Heteromer Q69607; Q9Y657; | 2×GOL; | ||||
Assess | ||||||
Crystal Structure of Spindlin1 bound to SPINDOC Docpep3 |
Heteromer Q9BUA3; Q9Y657; | |||||
Assess | ||||||
Crystal Structure of Spindlin1 bound to SPINDOC Docpep2 |
Heteromer Q9BUA3; Q9Y657; | |||||
Assess | ||||||
Crystal structure of human Spindlin1 bound to histone H3K4me3 peptide |
Heteromer Q71DI3; Q9Y657; | 1×MRD; 1×MPD; 1×MG; 1×CL; | ||||
Assess | ||||||
Crystal structure of human Spindlin1 bound to histone H3(K4me3-R8me2a) peptide |
Heteromer Q71DI3; Q9Y657; | 2×CL; 1×MG; | ||||
Assess | ||||||
Crystal structure of human Spindlin1 bound to histone H3(K4me3-R8me2s) peptide |
Heteromer Q71DI3; Q9Y657; | 1×MG; | ||||
Assess | ||||||
Crystal Structure of Spindlin1 | homo-2-mer | 2×PO4; | ||||
Assess | ||||||
Crystal structure of Spindlin1 in complex with the inhibitor VinSpinIn | monomer | 1×H7T; 4×DMS; 1×GLY; | ||||
Assess | ||||||
Crystal structure of Spindlin1 in complex with the Methyltransferase inhibitor A366 | monomer | 2×2OD; 2×EDO; 1×DMS; 1×MPD; 1×GOL; 1×NA; | ||||
Assess | ||||||
Crystal structure of Spindlin1 in complex with the inhibitor XY49-92B | monomer | 1×V88; 1×PO4; 2×MPD; 1×CL; 1×GLY; 2×NA; | ||||
Assess | ||||||
Crystal structure of Spindlin1 in complex with the inhibitor TD001851a | monomer | 1×MPD; 1×MRD; 1×DMS; 1×H7Q; 1×CL; | ||||
Assess | ||||||
Crystal structure of Spindlin1 in complex with the inhibitor MS31 | monomer | 2×MPD; 2×DMS; 1×JC5; 1×GLY; 1×PO4; 1×GOL; | ||||
Assess | ||||||
Crystal structure of Spindlin1 bound to compound EML631 | monomer | 1×6PD; 1×MG; 1×CL; | ||||
Assess | ||||||
Crystal structure of Spindlin1 bound to compound EML405 | monomer | 1×6P9; 1×MG; 1×CL; | ||||
Assess | ||||||
Crystal structure of human Spindlin1 in complex with a histone H4K20(me3) peptide | monomer | |||||
Assess |
1 SWISS-MODEL model
Template | Oligo-state | QMEANDisCo | Range | Ligands | Trg-Tpl Seq id (%) | |
---|---|---|---|---|---|---|
7bqz.1.A | monomer | 0.79 | 100.00 | |||
Assess |